Pens and prospering as a manufacturer

Pens and prospering as a manufacturer

November 18, 2019

Melbourne, Victoria, Australia

Trajan Scientific and Medical (Trajan) has been featured by @AuManufacturing, highlighting Trajan's ongoing investment into the development of hemaPEN®, and other technologies to address emerging trends in healthcare.

The article outlines Trajan's collaborative approach to R&D, and success in identifying and manufacturing niche technologies for global markets.

Read the full article at @AUManufacturing - Pens and prospering as a manufacturer.

More information
hemaPEN
About us
@AuManufacturing

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1908 568 844
media@trajanscimed.com

The hemaPEN® is a device supplied for research purposes only. This device is not for therapeutic or diagnostic use.




Also in News

CE mark for Trajan’s hemaPEN blood microsampling device, now available for diagnostic use across EU and UK
CE mark for Trajan’s hemaPEN blood microsampling device, now available for diagnostic use across EU and UK

May 07, 2020

Trajan Scientific and Medical has declared hemaPEN® compliance with EU IVD Directive 98/79/EC, and its release for in vitro diagnostic use in the EU and UK. This follows the hemaPEN’s recent addition to the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class 1 IVD device.

Read More

New Trajan microtome blades, for any tissue type
New Trajan microtome blades, for any tissue type

April 28, 2020

Trajan Scientific and Medical releases new microtome blades in Australia, New Zealand, UK and EU, to provide the blade of choice for any tissue type. For histologists who have trouble finding a blade that offers both exceptional cutting and longevity, Trajan microtome blades have been designed to enable smooth and precise sectioning across a wide range of tissue specimens.

Read More

The third leg in at-home healthcare – microsampling
The third leg in at-home healthcare – microsampling

April 16, 2020

Blood microsampling technology has been evolving over the past few years. Designed to cut the need for central pathology collection centers and trained phlebotomists. It enables the collection of very small, accurate blood samples in the home.

Read More